Announced
Completed
Alcedo completed the acquisition of a 64.2% of Ekalab for $42m.
Synopsis
Alcedo, a private equity firm, completed the acquisition of a 64.2% of Ekalab , a company active in the production and marketing of food supplements, nutraceuticals, phytotherapics, pharmaceuticals and medical devices, for $42m.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Bidder Team (12)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite